+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Combination Therapy Drug"

From
Frontiers in Clinical Drug Research - HIV: Volume 5 - Product Thumbnail Image

Frontiers in Clinical Drug Research - HIV: Volume 5

  • Book
  • October 2021
  • 168 Pages
From
Successful Drug Discovery, Volume 4. Edition No. 1 - Product Thumbnail Image

Successful Drug Discovery, Volume 4. Edition No. 1

  • Book
  • September 2019
  • 272 Pages
Loading Indicator

The Combination Therapy Drug market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs that combine two or more active ingredients. These drugs are used to treat a variety of conditions, including cardiovascular disease, diabetes, and cancer. Combination therapy drugs are designed to provide a more effective treatment than single-agent drugs, as they can target multiple pathways and provide a more comprehensive approach to treatment. The Combination Therapy Drug market is highly competitive, with many large pharmaceutical companies investing heavily in research and development. Companies in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more